Abstract
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is based on the conversion of MTT into formazan crystals by living cells, which determines mitochondrial activity. Since for most cell populations the total mitochondrial activity is related to the number of viable cells, this assay is broadly used to measure the in vitro cytotoxic effects of drugs on cell lines or primary patient cells. In this chapter the protocol of the assay is described including important considerations relevant for each step of the assay as well as its limitations and possible applications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Kaspers, G.J., Pieters, R., Van Zantwijk, CH., Van Wering, E.R., Van Der Does-Van Den Berg, A., Veerman, A.J. (1998) Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood. 92, 259–266.
Salomons, G.S., Smets, L.A., Verwijs-Janssen, M., Hart, A.A., Haarman, E.G., Kaspers, G.J., Wering, E.V., Der Does-Van Den Berg, A.V., Kamps, W.A. (1999) Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia. 13, 1574–1580.
Kaspers G.J., Veerman A.J., Pieters R, Van Zantwijk CH., Smets L.A., Van Wering E.R., Van Der Does-Van Den Berg A. (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 90, 2723–2729.
Kaspers, G.J., Wijnands, J.J., Hartmann, R., Huismans, L., Loonen, A.H., Stackelberg, A., Henze, G., Pieters, R., Hählen, K., Van Wering, E.R., Veerman, A.J. (2005) Immuno-phenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer. 41, 1300–1303.
Hubeek, I., Peters, G.J., Broekhuizen, R., Zwaan, C.M., Kaaijk, P., van Wering, E.S., Gibson, B.E., Creutzig, U., Janka-Schaub, G.E., den Boer, M.L., Pieters, R., Kaspers, G.J. (2006) In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. Haematologica. 91, 17–23.
Oerlemans, R., Franke, N.E., Assaraf, Y.G., Cloos, J., van Zantwijk, I., Berkers, C.R., Scheffer, G.L., Debipersad, K., Vojtekova, K., Lemos, C., van der Heijden, J.W., Ylstra, B., Peters, G.J., Kaspers, G.J., Dijkmans, B.A., Scheper, R.J., Jansen, G. (2008) Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood. 112, 2489–2499.
Klumper E., Pieters R., Veerman A.J., Huismans D.R., Loonen A.H., Hählen K., Kaspers G.J., van Wering E.R., Hartmann R., Henze G. (1995) In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood. 86, 3861–3868.
Kaspers G.J., Veerman A.J., Pieters R, Broekema G.J., Huismans D.R., Kazemier K.M., Loonen A.H., Rottier M.A., van Zantwijk CH., Hählen K. (1994) Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer. 70, 1047–1052.
Acknowledgments
This work was supported by KiKa “Stichting Kinderen Kankervrij” – Dutch Children Cancer-free foundation and VONK “VUmc Onderzoek Naar Kinderkanker” foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
van Meerloo, J., Kaspers, G.J.L., Cloos, J. (2011). Cell Sensitivity Assays: The MTT Assay. In: Cree, I. (eds) Cancer Cell Culture. Methods in Molecular Biology, vol 731. Humana Press. https://doi.org/10.1007/978-1-61779-080-5_20
Download citation
DOI: https://doi.org/10.1007/978-1-61779-080-5_20
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-079-9
Online ISBN: 978-1-61779-080-5
eBook Packages: Springer Protocols